Total planned funding: $130,988,040
Allocations
Countries/Regions
Ukraine | $130,988,040 |
Organizational Types
Private Contractor | $36,614,481 |
NGO | $27,022,354 |
Unknown | $21,399,720 |
Multi-lateral Agency | $16,801,607 |
Own Agency | $14,679,371 |
University | $6,160,000 |
Other USG Agency | $5,510,507 |
Implementing Agency | $2,800,000 |
Program Areas
Governance and Systems | $56,559,192 |
Treatment | $25,404,342 |
Prevention | $16,772,601 |
Testing | $11,841,618 |
Care | $10,851,246 |
Management and Operations | $9,146,341 |
Budget Codes
OHSS: Health Systems Strengthening | $27,591,354 |
HVSI: Strategic Information | $18,026,869 |
HTXS: Treatment: Adult Treatment | $13,999,052 |
HVCT: Testing: HIV Testing and Counseling | $11,841,618 |
HTXD: Treatment: ARV Drugs | $11,405,290 |
HLAB: Laboratory Infrastructure | $10,940,969 |
HVMS: Management and Operations | $9,146,341 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $8,759,566 |
HVTB: Care: TB/HIV | $7,063,845 |
HVOP: Sexual Prevention: Other Sexual Prevention | $4,732,255 |
HMBL: Biomedical Prevention: Blood Safety | $3,210,484 |
HBHC: Care: Adult Care and Support | $2,245,590 |
HKID: Care: Orphans and Vulnerable Children | $1,541,811 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $70,296 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $0 |
Top Partner Programs
Not Available:
$22,104,436
Countries/Regions
Chemonics International:
$18,839,470
Countries/Regions
Pact, Inc.:
$14,545,315
Countries/Regions
Deloitte Consulting Limited:
$13,725,011
Countries/Regions
USG Aggregated Agencies:
$11,593,784
Countries/Regions